Products for Research Use Only
RegisterLogin

SGC0946 TFA

CAT: 0013-GTR19263915-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19263915-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SGC0946 TFA is a selective inhibitor of DOT1L with an IC50 value of 0.3 nM. It induces G1 phase arrest in cancer cells by inhibiting DOT1L and reduces cellular self-renewal and metastatic potential while promoting cell differentiation. SGC0946 TFA is applicable in research for tumors such as leukemia and breast cancer and serves as a probe for studying the cellular mechanisms of DOT1L in both normal and diseased cells.
Field of Research
Epigenetics & Chromatin, Immunology & Inflammation
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19171482-01SGC0946
GTR19163026-01SGC0946
GTR19221711-01Albiglutide TFA
GTR19221625-01Homocarnosine TFA
GTR19221513-01Mifamurtide TFA
GTR19220144-01Chlorotoxin TFA
GTR19220136-01FC131 TFA
GTR19219465-01Elarofiban TFA
GTR19213644-01Traxanox TFA
GTR19213125Aβ-IN-1 TFA

Alternative Products

CatalogName
HY-15650-01SGC0946
T211545-01SGC0946 TFA
HY-15650ASGC0946 (TFA)
bs-60101C-01SGC0946 --- DOT1L inhibitor

Popular Products